BioVie 10K 2018 Annual report | BIVI Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: abbreviated, absorbed, Academy, accuracy, advice, allegation, alleged, alleging, alpha, Amylyx, ANDA, anInter, antibiotic, anticompetitive, Appendix, Article, assign, assigned, ASU, Avenue, background, bacteriology, battery, BBA, BDO, Beach, Berman, bioavailability, Biochemistry, bioequivalent, Book, borrowed, Bosch, Boulevard, branded, Brian, bridge, bring, Buyout, CA, California, cancer, career, carryover, cellular, CFO, challenge, challenged, charter, chemical, Chicago, Children, circumvented, claim, CMO, Colorado, commonplace, composed, composition, comprised, conceived, Consolidated, context, contractor, convenience, COO, coordinating, copy, Cork, COSO, counted, counterclaim, court, Cryoport, Cuang, custodian, Database, Debenture, debilitating, deceptive, defective, Deferral, deficit, deliverable, Department, depressing, device, diagnose, diagnosed, diminished, disagree, dissuade, Distinguishing, district, DLx, drawn, drew, duly, easy, Easylink, EC, EisnerAmper, Elliott, enable, encounter, entail, entirety, Equivalence, essential, EST, EU, exceeding, Exide, experimental, exploit, Ferring, fill, fintech, Flagyl, Florida, footnote, forward, freestanding, function, GAAP, GD, Gene, grantor, Hague, half, HCUP, Hearing, hereunder, Hong, immaterial, Immuron, inadequacy, incorrect, indefinite, indexed, Inerpan, Influx, injunction, inquiry, intent, intentionally, interferon, invalid, invalidated, invalidating, invalidity, inventorship, IP, IR, irrevocably, Jaime, Jeremy, Joanne, JWK, Kantum, Kim, Kong, KPMG, Krisber, Landmark, largest, Leveraged, likelihood, LLP, Los, mandatorily, Markham, Master, metronidazole, misleading, misuse, molecular, Monica, Motion, moved, Multiferon, mutual, nafarelin, Nationwide, NCE, negotiate, NIH, nominating, nomination, Noncontrolling, nonperformance, Nonpublic, NYU, offset, OID, Opposition, opted, Oral, Orange, ordinary, oversaw, oversee, overseeing, owed, owner, page, penalty, Penelope, pension, Petitioner, pivotal, powder, prepaid, Prestolite, prevalence, prioritize, prohibiting, prominent, published, question, randomized, recognition, reconstitute, recurring, redeemable, redemption, regular, replacement, Reply, reputation, residency, resumed, retrospectively, rotation, route, Rush, Santa, save, Science, Scientist, Scotland, screening, seizure, shortage, simultaneously, sooner, space, Specimen, sporadic, standing, statutorily, Ste, Stern, Strathclyde, substance, Subtopic, supplement, Supplemental, Synarel, Tapimmune, thereon, thereunto, threshold, Topic, topline, Treasurer, Trust, Trustee, unanticipated, unchanged, undersigned, unenforceability, unenforceable, unestablished, unfavorable, unpatentable, unpredictable, unqualified, unregistered, unvalidated, uplisting, USA, usage, Vaccine, version, Viragen, virology, waive, waived, Wendy, wife, Wilshire, wisdom, withheld, workday

Removed: AICPA, aim, allocated, analogue, arisen, attestation, Beverly, biotech, BIVI, broadly, budget, Bulletin, buyer, calculation, Center, choosing, CIPT, complementary, constitute, contact, customer, declare, defining, depending, detail, detailed, detection, devote, dilutive, disposition, EITF, emerging, enhanced, ensuring, evidenced, explore, failing, feet, filer, forecasted, formalized, founding, generating, golden, hand, harbor, impossible, inInternal, judgment, Jumpstart, lapse, lowest, MA, merged, modification, nonbinding, offered, opportunity, organizational, OTC, Overview, pace, parachute, permit, pertain, promise, proscribed, PROSPECTIVE, qualification, redesign, Reform, relying, retail, reveal, Rue, segregation, simple, simpler, sourcing, SPECULATIVE, square, Suite, symbol, theInternal, timeline, traded, transition, understood, uneconomical, venture, viewed, volatile, vote, working, workload

(1)	The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m (a) or 78o(d)); and

(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

BioVie (BIVI) 10-K2018 FY Annual report

Content analysis